Association of tertiles of PCSK9 with cardiovascular outcome; Kaplan-Meier analysis followed by log-rank test.

Associations of serially measured PCSK9, LDLR and MPO with clinical outcomes in heart failure

Bouwens, Elke
Schuurman, Anne-Sophie
Akkerhuis, Martijn
Manintveld, Olivier
Caliskan, Kadir
van Ramshorst, J
Germans, T
Umans, VA
Boersma, Eric
Kardys, Isabella

March 2021

Aim: To investigate the temporal evolution of plasma proprotein convertase subtilisin/kexin type 9 (...

Correlation between PCSK9 and estimated glomerular filtration rate (GFR) assessed by Spearman test in LURIC participants.

Kyrill S. Rogacev (360745)
Gunnar H. Heine (360752)
Günther Silbernagel (106282)
Marcus E. Kleber (106276)
Sarah Seiler (847586)
Insa Emrich (847587)
Simone Lennartz (847588)
Christian Werner (351232)
Adam M. Zawada (847589)
Danilo Fliser (360750)
Michael Böhm (65063)
Winfried März (106288)
Hubert Scharnagl (435522)
Ulrich Laufs (360751)

January 2016

Correlation between PCSK9 and estimated glomerular filtration rate (GFR) assessed by Spearman tes...

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina

Caselli C.
Del Turco S.
Ragusa R.
Lorenzoni V.
De Graaf M.
Basta G.
Scholte A.
De Caterina R.
Neglia D.

January 2019

Objective: Aim of this study was to evaluate the relationship of plasma PCSK9 with metabolic and inf...

Kaplan-Meier estimates of adverse cardiovascular events according to categories of relative changes (P-value of log rank test = 0.001).

Dhayana Dallmeier (106279)
Michael J. Pencina (582107)
Iris Rajman (686989)
Wolfgang Koenig (26222)
Dietrich Rothenbacher (240639)
Hermann Brenner (63649)

January 2015

Kaplan-Meier estimates of adverse cardiovascular events according to categories of relative chang...

Kaplan-Meier curves showing incident cardiovascular events according to GlycA, P≤0.001 by log-rank test (A) and high sensitivity C-reactive protein (hsCRP), P≤0.001 by log-rank test (B).

Eke G. Gruppen (799169)
Ineke J. Riphagen (702667)
Margery A. Connelly (799170)
James D. Otvos (799171)
Stephan J. L. Bakker (111215)
Robin P. F. Dullaart (196402)

September 2015

Kaplan-Meier curves showing incident cardiovascular events according to GlycA, P≤0.001 by ...

Correlation of PCSK9 and Serum sdLDL Levels and Other Demographic and Laboratory Indicators in Healthy Individuals

Reza Hosseini-Fard
Mohsen Khosravi
Azim Shamseddin Beiranvand
Saeid Taghilou
Meysam Havasimeher
Asghar Mohammadi
Sadegh Piran Kashani
Elham Soltanmohammadi
Sadegh Piran Kashani

May 2018

Background and Objectives: Atherosclerosis is a type of cardiovascular disease (CVD), which is known...

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis-The IMPROVE Study

Coggi, Daniela
Frigerio, Beatrice
Bonomi, Alice
Ruscica, Massimiliano
Ferri, Nicola
Sansaro, Daniela
Ravani, Alessio
Ferrante, Palma
Damigella, Manuela
Veglia, Fabrizio
Capra, Nicolo
Lupo, Maria Giovanna
Macchi, Chiara
Savonen, Kai
Silveira, Angela
Kurl, Sudhir
Giral, Philippe
Pirro, Matteo
Strawbridge, Rona Juliette
Gigante, Bruna
Smit, Andries Jan
Tremoli, Elena
Amato, Mauro
Baldassarre, Damiano

July 2021

(1) Background and purpose: circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one...

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study

Daniela Coggi
Beatrice Frigerio
Alice Bonomi
Massimiliano Ruscica
Nicola Ferri
Daniela Sansaro
Alessio Ravani
Palma Ferrante
Manuela Damigella
Fabrizio Veglia
Nicolò Capra
Maria Giovanna Lupo
Chiara Macchi
Kai Savonen
Angela Silveira
Sudhir Kurl
Philippe Giral
Matteo Pirro
Rona Juliette Strawbridge
Bruna Gigante
Andries Jan Smit
Elena Tremoli
Mauro Amato
Damiano Baldassarre
on behalf of the IMPROVE Study Group

July 2021

(1) Background and purpose: circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one...

Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation

Pastori, Daniele
Nocella, Cristina
Farcomeni, Alessio
Bartimoccia, Simona
Santulli, Maria
VASATURO, Fortunata
Carnevale, Roberto
Menichelli, Danilo
Violi, Francesco
Pignatelli, Pasquale
Saliola, Mirella
Casciaro, Marco Antonio
Ferro, Domenico
Vicario, Tommasa
Albanese, Fabiana
Cribari, Francesco
Paladino, Alberto
DEL SOLE, FRANCESCO
Novo, Marta
Cammisotto, Vittoria
Andreozzi, Paola
DI STEFANO, Tiziana
IANNUCCI, Patrizia
SABBATINI, Elio

January 2017

BACKGROUND Soluble proprotein convertase subtilisin/kexin type 9 (PCSK9) has been shown to be predic...

Relationship between circulating PCSK9 and markers of subclinical atherosclerosis—the improve study

Coggi D.
Frigerio B.
Bonomi A.
Ruscica M.
Ferri N.
Sansaro D.
Ravani A.
Ferrante P.
Damigella M.
Veglia F.
Capra N.
Lupo M. G.
Macchi C.
Savonen K.
Silveira A.
Kurl S.
Giral P.
Pirro M.
Strawbridge R. J.
Gigante B.
Smit A. J.
Tremoli E.
Amato M.
Baldassarre D.

January 2021

(1) Background and purpose: Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one...

Kaplan-Meier analysis of TTR and OS of patients with HCC.

Guoliang Qiao (621641)
Yuan Le (621642)
Jun Li (6494)
Lianghuan Wang (621643)
Feng Shen (151470)

August 2014

(A,B) Kaplan-Meier curves of the correlation between p-Ser9-GSK-3β expression level and (A) recur...

PCSK9 in acute coronary syndrome: analysis of associations with clinical and laboratory characteristics

Yu. A. Drenina
K. Yu. Nikolaev

September 2020

The article discusses a literature review reflecting the importance of identifying novel biomarkers ...

Kaplan-Meier survival analysis with Log-rank test according to the expressions of PARP1, γH2AX, BRCA1, and BRCA2 in various histological types of soft-tissue sarcomas.

Kyoung Min Kim (436671)
Young Jae Moon (453249)
See-Hyoung Park (246508)
Hye Jeong Park (1649656)
Sung Il Wang (3127050)
Ho Sung Park (134939)
Ho Lee (453255)
Keun Sang Kwon (453250)
Woo Sung Moon (134941)
Dong Geun Lee (3127053)
Jung Ryul Kim (453248)
Kyu Yun Jang (134932)

September 2016

Kaplan-Meier survival analysis with Log-rank test according to the expressions of PARP1, γH2AX, B...

Kaplan-Meier survival curves in the four predefined subgroups.

Elena Candela (6019523)
Francisco Marín (4441882)
José Miguel Rivera-Caravaca (4441879)
Nuria Vicente Ibarra (6019526)
Luna Carrillo (6019529)
María Asunción Esteve-Pastor (4441894)
Teresa Lozano (4452778)
Manuel Jesús Macías (6019532)
Vicente Pernias (6019535)
Miriam Sandín (6019538)
Esteban Orenes-Piñero (6019541)
Miriam Quintana-Giner (6019544)
Ignacio Hortelano (6019547)
Beatriz Villamía (6019550)
Andrea Veliz (6019553)
Mariano Valdés (4441891)
Juan G. Martínez-Martínez (6019556)
Juan M. Ruiz-Nodar (6019559)

November 2018

A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...

Associations between miR transcoronary gradients and surrogate markers of cardiovascular disease.

R. Jay Widmer (643337)
Woo-Young Chung (643338)
Joerg Herrmann (333656)
Kyra L. Jordan (643339)
Lilach O. Lerman (333658)
Amir Lerman (333660)

October 2014

Multivariable analysis of miR levels and certain surrogate markers of CHD. Spearman's rank correl...

Associations of serially measured PCSK9, LDLR and MPO with clinical outcomes in heart failure

Bouwens, Elke
Schuurman, Anne-Sophie
Akkerhuis, Martijn
Manintveld, Olivier
Caliskan, Kadir
van Ramshorst, J
Germans, T
Umans, VA
Boersma, Eric
Kardys, Isabella

March 2021

Aim: To investigate the temporal evolution of plasma proprotein convertase subtilisin/kexin type 9 (...

Correlation between PCSK9 and estimated glomerular filtration rate (GFR) assessed by Spearman test in LURIC participants.

Kyrill S. Rogacev (360745)
Gunnar H. Heine (360752)
Günther Silbernagel (106282)
Marcus E. Kleber (106276)
Sarah Seiler (847586)
Insa Emrich (847587)
Simone Lennartz (847588)
Christian Werner (351232)
Adam M. Zawada (847589)
Danilo Fliser (360750)
Michael Böhm (65063)
Winfried März (106288)
Hubert Scharnagl (435522)
Ulrich Laufs (360751)

January 2016

Correlation between PCSK9 and estimated glomerular filtration rate (GFR) assessed by Spearman tes...

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina

Caselli C.
Del Turco S.
Ragusa R.
Lorenzoni V.
De Graaf M.
Basta G.
Scholte A.
De Caterina R.
Neglia D.

January 2019

Objective: Aim of this study was to evaluate the relationship of plasma PCSK9 with metabolic and inf...

Kaplan-Meier estimates of adverse cardiovascular events according to categories of relative changes (P-value of log rank test = 0.001).

Dhayana Dallmeier (106279)
Michael J. Pencina (582107)
Iris Rajman (686989)
Wolfgang Koenig (26222)
Dietrich Rothenbacher (240639)
Hermann Brenner (63649)

January 2015

Kaplan-Meier estimates of adverse cardiovascular events according to categories of relative chang...

Kaplan-Meier curves showing incident cardiovascular events according to GlycA, P≤0.001 by log-rank test (A) and high sensitivity C-reactive protein (hsCRP), P≤0.001 by log-rank test (B).

Eke G. Gruppen (799169)
Ineke J. Riphagen (702667)
Margery A. Connelly (799170)
James D. Otvos (799171)
Stephan J. L. Bakker (111215)
Robin P. F. Dullaart (196402)

September 2015

Kaplan-Meier curves showing incident cardiovascular events according to GlycA, P≤0.001 by ...

Correlation of PCSK9 and Serum sdLDL Levels and Other Demographic and Laboratory Indicators in Healthy Individuals

Reza Hosseini-Fard
Mohsen Khosravi
Azim Shamseddin Beiranvand
Saeid Taghilou
Meysam Havasimeher
Asghar Mohammadi
Sadegh Piran Kashani
Elham Soltanmohammadi
Sadegh Piran Kashani

May 2018

Background and Objectives: Atherosclerosis is a type of cardiovascular disease (CVD), which is known...

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis-The IMPROVE Study

Coggi, Daniela
Frigerio, Beatrice
Bonomi, Alice
Ruscica, Massimiliano
Ferri, Nicola
Sansaro, Daniela
Ravani, Alessio
Ferrante, Palma
Damigella, Manuela
Veglia, Fabrizio
Capra, Nicolo
Lupo, Maria Giovanna
Macchi, Chiara
Savonen, Kai
Silveira, Angela
Kurl, Sudhir
Giral, Philippe
Pirro, Matteo
Strawbridge, Rona Juliette
Gigante, Bruna
Smit, Andries Jan
Tremoli, Elena
Amato, Mauro
Baldassarre, Damiano

July 2021

(1) Background and purpose: circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one...

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study

Daniela Coggi
Beatrice Frigerio
Alice Bonomi
Massimiliano Ruscica
Nicola Ferri
Daniela Sansaro
Alessio Ravani
Palma Ferrante
Manuela Damigella
Fabrizio Veglia
Nicolò Capra
Maria Giovanna Lupo
Chiara Macchi
Kai Savonen
Angela Silveira
Sudhir Kurl
Philippe Giral
Matteo Pirro
Rona Juliette Strawbridge
Bruna Gigante
Andries Jan Smit
Elena Tremoli
Mauro Amato
Damiano Baldassarre
on behalf of the IMPROVE Study Group

July 2021

(1) Background and purpose: circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one...

Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation

Pastori, Daniele
Nocella, Cristina
Farcomeni, Alessio
Bartimoccia, Simona
Santulli, Maria
VASATURO, Fortunata
Carnevale, Roberto
Menichelli, Danilo
Violi, Francesco
Pignatelli, Pasquale
Saliola, Mirella
Casciaro, Marco Antonio
Ferro, Domenico
Vicario, Tommasa
Albanese, Fabiana
Cribari, Francesco
Paladino, Alberto
DEL SOLE, FRANCESCO
Novo, Marta
Cammisotto, Vittoria
Andreozzi, Paola
DI STEFANO, Tiziana
IANNUCCI, Patrizia
SABBATINI, Elio

January 2017

BACKGROUND Soluble proprotein convertase subtilisin/kexin type 9 (PCSK9) has been shown to be predic...

Relationship between circulating PCSK9 and markers of subclinical atherosclerosis—the improve study

Coggi D.
Frigerio B.
Bonomi A.
Ruscica M.
Ferri N.
Sansaro D.
Ravani A.
Ferrante P.
Damigella M.
Veglia F.
Capra N.
Lupo M. G.
Macchi C.
Savonen K.
Silveira A.
Kurl S.
Giral P.
Pirro M.
Strawbridge R. J.
Gigante B.
Smit A. J.
Tremoli E.
Amato M.
Baldassarre D.

January 2021

(1) Background and purpose: Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one...

Kaplan-Meier analysis of TTR and OS of patients with HCC.

Guoliang Qiao (621641)
Yuan Le (621642)
Jun Li (6494)
Lianghuan Wang (621643)
Feng Shen (151470)

August 2014

(A,B) Kaplan-Meier curves of the correlation between p-Ser9-GSK-3β expression level and (A) recur...

PCSK9 in acute coronary syndrome: analysis of associations with clinical and laboratory characteristics

Yu. A. Drenina
K. Yu. Nikolaev

September 2020

The article discusses a literature review reflecting the importance of identifying novel biomarkers ...

Kaplan-Meier survival analysis with Log-rank test according to the expressions of PARP1, γH2AX, BRCA1, and BRCA2 in various histological types of soft-tissue sarcomas.

Kyoung Min Kim (436671)
Young Jae Moon (453249)
See-Hyoung Park (246508)
Hye Jeong Park (1649656)
Sung Il Wang (3127050)
Ho Sung Park (134939)
Ho Lee (453255)
Keun Sang Kwon (453250)
Woo Sung Moon (134941)
Dong Geun Lee (3127053)
Jung Ryul Kim (453248)
Kyu Yun Jang (134932)

September 2016

Kaplan-Meier survival analysis with Log-rank test according to the expressions of PARP1, γH2AX, B...

Kaplan-Meier survival curves in the four predefined subgroups.

Elena Candela (6019523)
Francisco Marín (4441882)
José Miguel Rivera-Caravaca (4441879)
Nuria Vicente Ibarra (6019526)
Luna Carrillo (6019529)
María Asunción Esteve-Pastor (4441894)
Teresa Lozano (4452778)
Manuel Jesús Macías (6019532)
Vicente Pernias (6019535)
Miriam Sandín (6019538)
Esteban Orenes-Piñero (6019541)
Miriam Quintana-Giner (6019544)
Ignacio Hortelano (6019547)
Beatriz Villamía (6019550)
Andrea Veliz (6019553)
Mariano Valdés (4441891)
Juan G. Martínez-Martínez (6019556)
Juan M. Ruiz-Nodar (6019559)

November 2018

A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...

Associations between miR transcoronary gradients and surrogate markers of cardiovascular disease.

R. Jay Widmer (643337)
Woo-Young Chung (643338)
Joerg Herrmann (333656)
Kyra L. Jordan (643339)
Lilach O. Lerman (333658)
Amir Lerman (333660)

October 2014

Multivariable analysis of miR levels and certain surrogate markers of CHD. Spearman's rank correl...

Associations of serially measured PCSK9, LDLR and MPO with clinical outcomes in heart failure

Bouwens, Elke
Schuurman, Anne-Sophie
Akkerhuis, Martijn
Manintveld, Olivier
Caliskan, Kadir
van Ramshorst, J
Germans, T
Umans, VA
Boersma, Eric
Kardys, Isabella

March 2021

Aim: To investigate the temporal evolution of plasma proprotein convertase subtilisin/kexin type 9 (...

Correlation between PCSK9 and estimated glomerular filtration rate (GFR) assessed by Spearman test in LURIC participants.

Kyrill S. Rogacev (360745)
Gunnar H. Heine (360752)
Günther Silbernagel (106282)
Marcus E. Kleber (106276)
Sarah Seiler (847586)
Insa Emrich (847587)
Simone Lennartz (847588)
Christian Werner (351232)
Adam M. Zawada (847589)
Danilo Fliser (360750)
Michael Böhm (65063)
Winfried März (106288)
Hubert Scharnagl (435522)
Ulrich Laufs (360751)

January 2016

Correlation between PCSK9 and estimated glomerular filtration rate (GFR) assessed by Spearman tes...

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina

Caselli C.
Del Turco S.
Ragusa R.
Lorenzoni V.
De Graaf M.
Basta G.
Scholte A.
De Caterina R.
Neglia D.

January 2019

Objective: Aim of this study was to evaluate the relationship of plasma PCSK9 with metabolic and inf...

Association of tertiles of PCSK9 with cardiovascular outcome; Kaplan-Meier analysis followed by log-rank test.

Abstract

Extracted data

Association of tertiles of PCSK9 with cardiovascular outcome; Kaplan-Meier analysis followed by log-rank test.

Abstract

Extracted data

Related items

Related items